n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Kidney Diseases in 3 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harding, P | 1 |
| Glass, WF | 1 |
| Scherer, SD | 1 |
| Sankaran, D | 1 |
| Bankovic-Calic, N | 1 |
| Ogborn, MR | 1 |
| Crow, G | 1 |
| Aukema, HM | 1 |
| Nakada, SY | 1 |
| Jerde, TJ | 1 |
| Bjorling, DE | 1 |
| Saban, R | 1 |
3 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Kidney Diseases
| Article | Year |
|---|---|
COX-2 inhibition potentiates the antiproteinuric effect of enalapril in uninephrectomized SHR.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Wei | 2003 |
Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease.
Topics: Animals; Cyclooxygenase Inhibitors; Kidney; Kidney Diseases; Nitrobenzenes; Prostaglandin-Endoperoxi | 2007 |
Selective cyclooxygenase-2 inhibitors reduce ureteral contraction in vitro: a better alternative for renal colic?
Topics: Animals; Colic; Cyclooxygenase Inhibitors; Dimethyl Sulfoxide; Humans; In Vitro Techniques; Indometh | 2000 |